Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Determinants of Unpaid Hospital Charges Among Non-Resident Foreign Patients: A Retrospective Single-Center Study in Tokyo, Japan. [PDF]
Saeki S +5 more
europepmc +1 more source
The influence of perceived threat on the motive attribution asymmetry bias for groups in conflict. [PDF]
Hughes RE, Stewart BD.
europepmc +1 more source
RETRACTION: Notch1 Protects Against Myocardial Ischaemia-Reperfusion Injury via Regulating Mitochondrial Fusion and Function. [PDF]
europepmc +1 more source
Rapid, effective, and affordable randomisation for emergency neonatal research in a low-resource setting: a feasibility randomised controlled trial. [PDF]
Burgoine K +16 more
europepmc +1 more source
The Interplay of Economic Resources, Family Decision Power, and Gender Ideology in China. [PDF]
Luo MH, Kan MY.
europepmc +1 more source
Retraction: "Three-dimensional digital design of orthopedic surgery for idiopathic scoliosis deformity: A case series". [PDF]
europepmc +1 more source
RETRACTION: CircPTPRM Accelerates Malignancy of Papillary Thyroid Cancer via miR-885-5p/DNMT3A Axis. [PDF]
europepmc +1 more source

